Business Description
Arecor Therapeutics PLC
ISIN : GB00BMWLM973
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 19.98 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.68 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.7 | |||||
3-Year EBITDA Growth Rate | -32.4 | |||||
3-Year EPS without NRI Growth Rate | 68.8 | |||||
3-Year FCF Growth Rate | -41.6 | |||||
3-Year Book Growth Rate | 123.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61 | |||||
9-Day RSI | 66.5 | |||||
14-Day RSI | 66.11 | |||||
6-1 Month Momentum % | -26.44 | |||||
12-1 Month Momentum % | -46.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.17 | |||||
Quick Ratio | 2.02 | |||||
Cash Ratio | 1.31 | |||||
Days Sales Outstanding | 176.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -0.05 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -200.63 | |||||
Net Margin % | -187.05 | |||||
FCF Margin % | -131.23 | |||||
ROE % | -63.85 | |||||
ROA % | -44.81 | |||||
ROIC % | -122.7 | |||||
ROC (Joel Greenblatt) % | -714.5 | |||||
ROCE % | -63.44 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.57 | |||||
PB Ratio | 5.1 | |||||
Price-to-Tangible-Book | 7.78 | |||||
EV-to-EBIT | -4.77 | |||||
EV-to-EBITDA | -5.03 | |||||
EV-to-Forward-EBITDA | -5.97 | |||||
EV-to-Revenue | 9.26 | |||||
EV-to-Forward-Revenue | 6.22 | |||||
EV-to-FCF | -7.03 | |||||
Price-to-Net-Current-Asset-Value | 9.42 | |||||
Price-to-Net-Cash | 59.67 | |||||
Earnings Yield (Greenblatt) % | -21 | |||||
FCF Yield % | -12.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Arecor Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5.316 | ||
EPS (TTM) (€) | -0.004 | ||
Beta | 0 | ||
Volatility % | 31.09 | ||
14-Day RSI | 66.11 | ||
14-Day ATR (€) | 0.043378 | ||
20-Day SMA (€) | 1.6565 | ||
12-1 Month Momentum % | -46.5 | ||
52-Week Range (€) | 1.44 - 2.8 | ||
Shares Outstanding (Mil) | 30.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arecor Therapeutics PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arecor Therapeutics PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Arecor Therapeutics PLC Frequently Asked Questions
What is Arecor Therapeutics PLC(FRA:6UI)'s stock price today?
When is next earnings date of Arecor Therapeutics PLC(FRA:6UI)?
Does Arecor Therapeutics PLC(FRA:6UI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |